These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 14973570

  • 1. Medicinal chemistry in academia: molecular recognition with biological receptors.
    Hof F, Diederich F.
    Chem Commun (Camb); 2004 Mar 07; (5):477-80. PubMed ID: 14973570
    [Abstract] [Full Text] [Related]

  • 2. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
    Zürcher M, Gottschalk T, Meyer S, Bur D, Diederich F.
    ChemMedChem; 2008 Feb 07; 3(2):237-40. PubMed ID: 17918177
    [No Abstract] [Full Text] [Related]

  • 3. Inhibitors of Plasmepsin II-potential antimalarial agents.
    Corminboeuf O, Dunet G, Hafsi M, Grimont J, Grisostomi C, Meyer S, Binkert C, Bur D, Jones A, Prade L, Brun R, Boss C.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6194-9. PubMed ID: 17000102
    [Abstract] [Full Text] [Related]

  • 4. Drug discovery and development in the age of molecular medicine.
    Vallance P, Levick M.
    Clin Pharmacol Ther; 2007 Oct 15; 82(4):363-6. PubMed ID: 17851574
    [Abstract] [Full Text] [Related]

  • 5. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y.
    J Chem Inf Model; 2005 Oct 15; 45(4):1082-100. PubMed ID: 16045304
    [Abstract] [Full Text] [Related]

  • 6. Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.
    Romeo S, Dell'Agli M, Parapini S, Rizzi L, Galli G, Mondani M, Sparatore A, Taramelli D, Bosisio E.
    Bioorg Med Chem Lett; 2004 Jun 07; 14(11):2931-4. PubMed ID: 15125962
    [Abstract] [Full Text] [Related]

  • 7. Ensemble-docking approach on BACE-1: pharmacophore perception and guidelines for drug design.
    Limongelli V, Marinelli L, Cosconati S, Braun HA, Schmidt B, Novellino E.
    ChemMedChem; 2007 May 07; 2(5):667-78. PubMed ID: 17407105
    [Abstract] [Full Text] [Related]

  • 8. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C, Fischel O, Cohen E.
    Chem Biol Drug Des; 2007 Jan 07; 69(1):75-82. PubMed ID: 17313460
    [Abstract] [Full Text] [Related]

  • 9. Drug Guru: a computer software program for drug design using medicinal chemistry rules.
    Stewart KD, Shiroda M, James CA.
    Bioorg Med Chem; 2006 Oct 15; 14(20):7011-22. PubMed ID: 16870456
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Timely synthetic support for medicinal chemists.
    Potoski J.
    Drug Discov Today; 2005 Jan 15; 10(2):115-20. PubMed ID: 15718160
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
    Muthas D, Nöteberg D, Sabnis YA, Hamelink E, Vrang L, Samuelsson B, Karlén A, Hallberg A.
    Bioorg Med Chem; 2005 Sep 15; 13(18):5371-90. PubMed ID: 16054370
    [Abstract] [Full Text] [Related]

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 15; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular recognition: the fragment approach in lead generation.
    Fattori D.
    Drug Discov Today; 2004 Mar 01; 9(5):229-38. PubMed ID: 14980541
    [Abstract] [Full Text] [Related]

  • 18. SAR maps: a new SAR visualization technique for medicinal chemists.
    Agrafiotis DK, Shemanarev M, Connolly PJ, Farnum M, Lobanov VS.
    J Med Chem; 2007 Nov 29; 50(24):5926-37. PubMed ID: 17958407
    [Abstract] [Full Text] [Related]

  • 19. The innovative crisis as a current pharmaceutical research problem: causes, consequences, responses and solutions.
    Bucurescu S.
    Eur Rev Med Pharmacol Sci; 2012 Mar 29; 16(3):305-9. PubMed ID: 22530345
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.